120 related articles for article (PubMed ID: 1901273)
21. Bernard-Soulier syndrome with severe bleeding: absent platelet glycoprotein Ib alpha due to a homozygous one-base deletion.
Li C; Pasquale DN; Roth GJ
Thromb Haemost; 1996 Nov; 76(5):670-4. PubMed ID: 8950770
[TBL] [Abstract][Full Text] [Related]
22. Evidence that an abnormality in the glycoprotein Ib alpha gene is not the cause of abnormal platelet function in a family with classic Bernard-Soulier disease.
Finch CN; Miller JL; Lyle VA; Handin RI
Blood; 1990 Jun; 75(12):2357-62. PubMed ID: 1972029
[TBL] [Abstract][Full Text] [Related]
23. Use of DDAVP in inherited and acquired platelet dysfunction.
DiMichele DM; Hathaway WE
Am J Hematol; 1990 Jan; 33(1):39-45. PubMed ID: 2293761
[TBL] [Abstract][Full Text] [Related]
24. Identification of a homozygous single base pair deletion in the gene coding for the human platelet glycoprotein Ib alpha causing Bernard-Soulier syndrome.
Simsek S; Admiraal LG; Modderman PW; van der Schoot CE; von dem Borne AE
Thromb Haemost; 1994 Sep; 72(3):444-9. PubMed ID: 7855797
[TBL] [Abstract][Full Text] [Related]
25. Post-DDAVP thrombocytopenia in type 2B von Willebrand disease is not associated with platelet consumption: failure to demonstrate glycocalicin increase or platelet activation.
Casonato A; Steffan A; Pontara E; Zucchetto A; Rossi C; De Marco L; Girolami A
Thromb Haemost; 1999 Feb; 81(2):224-8. PubMed ID: 10063996
[TBL] [Abstract][Full Text] [Related]
26. The role of platelet membrane glycoproteins Ib and IIb-IIIa in platelet adherence to human artery subendothelium.
Sakariassen KS; Nievelstein PF; Coller BS; Sixma JJ
Br J Haematol; 1986 Aug; 63(4):681-91. PubMed ID: 2942171
[TBL] [Abstract][Full Text] [Related]
27. Molecular defects in the Bernard-Soulier syndrome: assessment of receptor genes, transcripts and proteins.
Roth GJ
C R Acad Sci III; 1996 Sep; 319(9):819-26. PubMed ID: 8952885
[TBL] [Abstract][Full Text] [Related]
28. Defective adhesion of blood platelets to vascular microfibrils in the Bernard-Soulier syndrome.
Fauvel-Lafève F; Tabaka V; Caen JP; Legrand YJ
Blood; 1993 Oct; 82(7):1985-8. PubMed ID: 8400250
[TBL] [Abstract][Full Text] [Related]
29. Residual amounts of glycoprotein Ib concomitant with near-absence of glycoprotein IX in platelets of Bernard-Soulier patients.
Drouin J; McGregor JL; Parmentier S; Izaguirre CA; Clemetson KJ
Blood; 1988 Sep; 72(3):1086-8. PubMed ID: 3416070
[TBL] [Abstract][Full Text] [Related]
30. Patients with Bernard-Soulier syndrome and different severity of the bleeding phenotype.
Boeckelmann D; Hengartner H; Greinacher A; Nowak-Göttl U; Sachs UJ; Peter K; Sandrock-Lang K; Zieger B
Blood Cells Mol Dis; 2017 Sep; 67():69-74. PubMed ID: 28131619
[TBL] [Abstract][Full Text] [Related]
31. 1-Desamino-8-D-arginine vasopressin (DDAVP) infusion in type IIB von Willebrand's disease: shortening of bleeding time and induction of a variable pseudothrombocytopenia.
Casonato A; Sartori MT; de Marco L; Girolami A
Thromb Haemost; 1990 Aug; 64(1):117-20. PubMed ID: 2274916
[TBL] [Abstract][Full Text] [Related]
32. Clinical phenotype in heterozygote and biallelic Bernard-Soulier syndrome--a case control study.
Bragadottir G; Birgisdottir ER; Gudmundsdottir BR; Hilmarsdottir B; Vidarsson B; Magnusson MK; Larsen OH; Sorensen B; Ingerslev J; Onundarson PT
Am J Hematol; 2015 Feb; 90(2):149-55. PubMed ID: 25370924
[TBL] [Abstract][Full Text] [Related]
33. Properties of the factor VIII after DDAVP (1-deamino-8-D-arginine vasopressin) infusion in normal subjects.
Takahashi H; Itoh M; Kobayashi I; Sakuragawa N; Shibata A
Tohoku J Exp Med; 1980 Oct; 132(2):133-40. PubMed ID: 6777902
[TBL] [Abstract][Full Text] [Related]
34. 1-Deamino (8-D-arginine) vasopressin infusion partially corrects platelet deposition on subendothelium in Bernard-Soulier syndrome: the role of factor VIII.
Lozano M; Escolar G; Bellucci S; Monteagudo J; Pico M; Ordinas A; Caen JP
Platelets; 1999; 10(2-3):141-5. PubMed ID: 16801084
[TBL] [Abstract][Full Text] [Related]
35. [Bernard-Soulier thrombocytopenia: clinical significance of a rare disorder].
Gengenbacher D; Tsakiris DA; Tichelli A; Marbet GA; Gratwohl A; Speck B
Schweiz Med Wochenschr; 1996 Oct; 126(43):1834-41. PubMed ID: 9005523
[TBL] [Abstract][Full Text] [Related]
36. Availability of endothelial von Willebrand factor and platelet function in diabetic patients infused with a vasopressin analogue.
Porta M
Diabetologia; 1982 Nov; 23(5):452-5. PubMed ID: 6816652
[TBL] [Abstract][Full Text] [Related]
37. First Turkish case of Bernard-Soulier syndrome associated with GPIX N45S.
Dağistan N; Kunishima S
Acta Haematol; 2007; 118(3):146-8. PubMed ID: 17804902
[TBL] [Abstract][Full Text] [Related]
38. Atherosclerosis and unstable angina in Bernard-Soulier syndrome.
Humphries JE; Yirinec BA; Hess CE
Am J Clin Pathol; 1992 May; 97(5):652-5. PubMed ID: 1575209
[TBL] [Abstract][Full Text] [Related]
39. DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor.
Casonato A; Dannhauser D; Pontara E; Bertomoro A; Orazi B; Santarossa L; Zerbinati P; Girolami A
Blood Coagul Fibrinolysis; 1996 Jul; 7(5):549-53. PubMed ID: 8874865
[TBL] [Abstract][Full Text] [Related]
40. Point mutation in a leucine-rich repeat of platelet glycoprotein Ib alpha resulting in the Bernard-Soulier syndrome.
Ware J; Russell SR; Marchese P; Murata M; Mazzucato M; De Marco L; Ruggeri ZM
J Clin Invest; 1993 Sep; 92(3):1213-20. PubMed ID: 7690774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
